- Home
- HERZ vs EDAP Comparison
HERZ vs EDAP Comparison
Compare HERZ & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HERZ
- EDAP
- Stock Information
- Founded
- HERZ N/A
- EDAP 1979
- Country
- HERZ United States
- EDAP France
- Employees
- HERZ N/A
- EDAP N/A
- Industry
- HERZ Investment Managers
- EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- HERZ Finance
- EDAP Health Care
- Exchange
- HERZ Nasdaq
- EDAP Nasdaq
- Market Cap
- HERZ 41.2M
- EDAP 46.7M
- IPO Year
- HERZ N/A
- EDAP 1997
- Fundamental
- Price
- HERZ $2.32
- EDAP $2.14
- Analyst Decision
- HERZ
- EDAP Buy
- Analyst Count
- HERZ 0
- EDAP 3
- Target Price
- HERZ N/A
- EDAP $8.50
- AVG Volume (30 Days)
- HERZ N/A
- EDAP 71.5K
- Earning Date
- HERZ N/A
- EDAP 11-06-2025
- Dividend Yield
- HERZ N/A
- EDAP N/A
- EPS Growth
- HERZ N/A
- EDAP N/A
- EPS
- HERZ N/A
- EDAP N/A
- Revenue
- HERZ N/A
- EDAP $74,008,221.00
- Revenue This Year
- HERZ N/A
- EDAP N/A
- Revenue Next Year
- HERZ N/A
- EDAP N/A
- P/E Ratio
- HERZ N/A
- EDAP N/A
- Revenue Growth
- HERZ N/A
- EDAP 1.56
- 52 Week Low
- HERZ N/A
- EDAP $1.21
- 52 Week High
- HERZ N/A
- EDAP $3.05
- Technical
- Relative Strength Index (RSI)
- HERZ 39.42
- EDAP 46.50
- Support Level
- HERZ $2.30
- EDAP $1.75
- Resistance Level
- HERZ $2.38
- EDAP $2.27
- Average True Range (ATR)
- HERZ 0.05
- EDAP 0.25
- MACD
- HERZ -0.01
- EDAP -0.04
- Stochastic Oscillator
- HERZ 19.41
- EDAP 37.50
About HERZ Herzfeld Credit Income Fund Inc. Common Stock
Herzfeld Credit Income Fund Inc is a non-diversified, closed-end management investment company. Its primary investment objective is to maximize risk-adjusted total returns, and its secondary investment objective is to generate high current income.
About EDAP EDAP TMS S.A.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.